| 1. |
王惠芬, 翟志芳. 彈性纖維假黃瘤研究進展[J]. 罕見病研究, 2023, 2(2): 313-318. DOI: 10.12376/j.issn.2097-0501.2023.02.019.Wang HF, Zhai ZF. Advances in pseudoxanthoma elasticum[J]. Journal of Rare Diseases, 2023, 2(2): 313-318. DOI: 10.12376/j.issn.2097-0501.2023.02.019.
|
| 2. |
Pfau K, Lengyel I, Ossewaarde-van Norel J, et al. Pseudoxanthoma elasticum-genetics, pathophysiology, and clinical presentation[J/OL]. Prog Retin Eye Res, 2024, 102: 101274[2024-05-28]. https://pubmed.ncbi.nlm.nih.gov/38815804/. DOI: 10.1016/j.preteyeres.2024.101274.
|
| 3. |
Dunetz GS. Pseudoxanthoma elasticum and angioid streaks[D]. Lithuanian University of Health Sciences (Lithuania), 2024. DOI:10.1093/qjmed/hcaa190.
|
| 4. |
Brokamp G, Mori M, Faith EF. Pseudoxanthoma elasticum[J/OL]. JAMA Dermatol, 2022, 158(1): 100[2022-01-01]. https://pubmed.ncbi.nlm.nih.gov/34787669/. DOI: 10.1001/jamadermatol.2021.4059.
|
| 5. |
Dias MQ, Gouveia N, Félix R, et al. Mutational spectrum and deep phenotyping in pseudoxanthoma elasticum: findings from a portuguese cohort[J]. Eur J Ophthalmol, 2025, 35(1): 112-118. DOI: 10.1177/11206721241247676.
|
| 6. |
Moitra K, Garcia S, Jaldin M, et al. ABCC6 and pseudoxanthoma elasticum: the face of a rare disease from genetics to advocacy[J/OL]. Int J Mol Sci, 2017, 18(7): 1488[2017-07-11]. https://pubmed.ncbi.nlm.nih.gov/28696355/. DOI: 10.3390/ijms18071488.
|
| 7. |
Legrand A, Cornez L, Samkari W, et al. Mutation spectrum in the ABCC6 gene and genotype-phenotype correlations in a French cohort with pseudoxanthoma elasticum[J]. Genet Med, 2017, 19(8): 909-917. DOI: 10.1038/gim.2016.213.
|
| 8. |
Saeidian AH, Youssefian L, Huang J, et al. Genetic heterogeneity of heritable ectopic mineralization disorders in a large international cohort[J]. Genet Med, 2022, 24(1): 75-86. DOI: 10.1016/j.gim.2021.08.011.
|
| 9. |
Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms[J]. J Invest Dermatol, 2010, 130(3): 661-670. DOI: 10.1038/jid.2009.411.
|
| 10. |
Jin L, Jiang Q, Wu Z, et al. Genetic heterogeneity of pseudoxanthoma elasticum: the Chinese signature profile of ABCC6 and ENPP1 mutations[J]. J Invest Dermatol, 2015, 135(5): 1294-1302. DOI: 10.1038/jid.2015.10.
|
| 11. |
Kringen MK, Stormo C, Berg JP, et al. Copy number variation in the ATP‐binding cassette transporter ABCC6 gene and ABCC6 pseudogenes in patients with pseudoxanthoma elasticum[J]. Mol Genet Genomic Med, 2015, 3(3): 233-237. DOI: 10.1002/mgg3.137.
|
| 12. |
Kozák E, Bartstra JW, de Jong PA, et al. Plasma level of pyrophosphate is low in pseudoxanthoma elasticum owing to mutations in the ABCC6 gene, but it does not correlate with ABCC6 genotype[J/OL]. J Clin Med, 2023, 12(3): 1047[2023-01-29]. https://pubmed.ncbi.nlm.nih.gov/36769695/. DOI: 10.3390/jcm12031047.
|
| 13. |
Mishra AV, Martens R, MacDonald IM. Pseudoxanthoma elasticum and retinitis pigmentosa in a patient with a novel mutation in the ABCC6 gene[J]. Ophthalmic Genet, 2024, 45(1): 108-111. DOI: 10.1080/13816810.2023.2219737.
|
| 14. |
Nollet L, Campens L, De Zaeytijd J, et al. Clinical and subclinical findings in heterozygous ABCC6 carriers: results from a Belgian cohort and clinical practice guidelines[J]. J Med Genet, 2022, 59(5): 496-504. DOI: 10.1136/jmedgenet-2020-107565.
|
| 15. |
Wakasa M, Nakagawa C, Takamura T, et al. A male patient with pseudoxanthoma elasticum caused by isodisomy of chromosome 16 containing a nonsense variant of the ABCC6 gene: a quarter-century treatment experience[J]. Atherosclerosis Plus, 2025, 60: 1-5. DOI: 10.1016/j.athplu.2025.03.001.
|
| 16. |
Iwanaga A, Utani A, Koike Y, et al. Clinical practice guidelines for pseudoxanthoma elasticum (2017): clinical practice guidelines for Pseudoxanthoma Elasticum Drafting Committe[J/OL]. J Dermatol, 2022, 49(3): e91-e98[2022-01-12]. https://pubmed.ncbi.nlm.nih.gov/35019155/. DOI: 10.1111/1346-8138.16301.
|
| 17. |
Wang QJ, ShenYP, Wu LQ, et al. Standards and guidelines for the interpretation of sequence variants[J]. Scientia Sinica (Vitae), 2017, 47(6): 668-688. DOI: 10.1360/N052017-00099.
|
| 18. |
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22(2): 245-257. DOI: 10.1038/s41436-019-0686-8.
|
| 19. |
Cai M, Que Y, Chen X, et al. 16p13.11 microdeletion/microduplication in fetuses: investigation of associated ultrasound phenotypes, genetic anomalies, and pregnancy outcome follow-up[J/OL]. BMC Pregnancy Childbirth, 2022, 22(1): 913[2022-12-07]. https://pubmed.ncbi.nlm.nih.gov/36476185/. DOI: 10.1186/s12884-022-05267-w.
|
| 20. |
黃思琪, 張譽馨, 趙梓廷, 等. 彈性纖維性假黃瘤一例[J]. 中國麻風皮膚病雜志, 2024, 40(9): 654-656. DOI: 10.12144/zgmfskin202409654.Huang SQ, Zhang YX, Zhao ZT, et al. Pseudoxanthoma elasticum: a case report[J]. Chin J Lepr Skin Dis, 2024, 40(9): 654-656. DOI: 10.12144/zgmfskin202409654.
|
| 21. |
烏日嘎, 韓建文. 彈性纖維性假黃瘤一例及基因檢測分析[J]. 中國麻風皮膚病雜志, 2024, 40(6): 419-421. DOI: 10.12144/zgmfskin202406419.Wu RG, Han JW. Pseudoxanthoma elasticum: a case report and gene mutation analysis[J]. Chin J Lepr Skin Dis, 2024, 40(6): 419-421. DOI: 10.12144/zgmfskin202406419.
|
| 22. |
Jansen RS, Kü?ükosmano?lu A, De Haas M, et al. ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release[J]. Proc Natl Acad Sci USA, 2013, 110(50): 20206-20211. DOI: 10.1073/pnas.1319582110.
|
| 23. |
Laghi A, Mandel VD, Zubba I, et al. Comprehensive analysis of pseudoxanthoma elasticum: epidemiological, genetic, and clinical findings from the leading Italian center[J]. Ital J Dermatol Venerol, 2024, 159(4): 430-435. DOI: 10.23736/S2784-8671.24.07949-0.
|
| 24. |
Li Q, Jiang Q, Pfendner E, et al. Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms[J]. Exp Dermatol, 2009, 18(1): 1-11. DOI: 10.1111/j.1600-0625.2008.00795.x.
|
| 25. |
Kranenburg G, de Jong PA, Bartstra JW, et al. Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum[J]. J Am Coll Cardiol, 2018, 71(10): 1117-1126. DOI: 10.1016/j.jacc.2017.12.062.
|
| 26. |
Bartstra JW, Risseeuw S, de Jong PA, et al. Genotype-phenotype correlation in pseudoxanthoma elasticum[J]. Atherosclerosis, 2021, 324: 18-26. DOI: 10.1016/j.atherosclerosis.2021.03.012.
|
| 27. |
Stumpf MJ, Schahab N, Nickenig G, et al. Therapy of pseudoxanthoma elasticum: current knowledge and future perspectives[J/OL]. Biomedicines, 2021, 9 (12): 1895[2021-12-13]. https://pubmed.ncbi.nlm.nih.gov/34944710/. DOI: 10.3390/biomedicines9121895.
|
| 28. |
Jacobs IJ, Obiri-Yeboah D, Stabach PR, et al. Novel treatment for PXE: recombinant ENPP1 enzyme therapy[J]. Mol Ther, 2024, 32(11): 3815-3820. DOI: 10.1016/j.ymthe.2024.09.028.
|
| 29. |
Ringpfeil F, Nakano A, Uitto J, et al. Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum[J]. Am J Hum Genet, 2001, 68(3): 642-652. DOI: 10.1086/318807.
|